(Q33935146)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681968%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

First BRET-based screening assay performed in budding yeast leads to the discovery of CDK5/p25 interaction inhibitors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681968%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681968%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Pierre Colas

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681968%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Caroline Corbel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681968%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Qian Wang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681968%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Hadjira Bousserouel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681968%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Amel Hamdi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681968%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Bing Zhang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681968%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Olivier Lozach

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681968%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Yoan Ferandin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681968%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Françoise Guéritte

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681968%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Cyril Couturier

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681968%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Stéphane Bach

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681968%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

16 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681968%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

published in

Biotechnology Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681968%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681968%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681968%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

860-870

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21681968%20AND%20SRC:MED&resulttype=core&format=json

Mammalian cyclin-dependent kinases

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

Cyclin-dependent kinase inhibitors: a survey of recent patent literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

Molecular mechanisms of neurodegeneration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

An unusual member of the Cdk family: Cdk5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

Neurotoxicity induces cleavage of p35 to p25 by calpain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

Extraneuronal roles of cyclin-dependent kinase 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

Inhibiting the cyclin-dependent kinase CDK5 blocks pancreatic cancer formation and progression through the suppression of Ras-Ral signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

Expression of CDK5/p35 in resected patients with non-small cell lung cancer: relation to prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

Roscovitine targets, protein kinases and pyridoxal kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

Identification of potential cellular targets of aloisine A by affinity chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

ATP-noncompetitive inhibitors of CDK-cyclin complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

Non-ATP competitive protein kinase inhibitors as anti-tumor therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

High-throughput screening assays to discover small-molecule inhibitors of protein interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

Yeast as a model for medical and medicinal research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

The BRET technology and its application to screening assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

A bioluminescence resonance energy transfer (BRET) system: application to interacting circadian clock proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

Biosensing and imaging based on bioluminescence resonance energy transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

Improved method for high efficiency transformation of intact yeast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

Activation of the Leptin Receptor by a Ligand-induced Conformational Change of Constitutive Receptor Dimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

Regulatable promoters of Saccharomyces cerevisiae: comparison of transcriptional activity and their use for heterologous expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

Using BRET to study chemical compound-induced disruptions of the p53-HDM2 interactions in live cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

Protein folding activity of ribosomal RNA is a selective target of two unrelated antiprion drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

Delayed treatment with systemic (S)-roscovitine provides neuroprotection and inhibits in vivo CDK5 activity increase in animal stroke models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

High-throughput screening of G protein-coupled receptor antagonists using a bioluminescence resonance energy transfer 1-based beta-arrestin2 recruitment assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

ERG6 and PDR5 regulate small lipophilic drug accumulation in yeast cells via distinct mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

A toxin-antitoxin module as a target for antimicrobial development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

Beta-arrestin-based Bret2 screening assay for the "non"-beta-arrestin binding CB1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

Development of a BRET2 screening assay using beta-arrestin 2 mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

Oligomerization of the yeast alpha-factor receptor: implications for dominant negative effects of mutant receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

Peptides derived from Cdk5 activator p35, specifically inhibit deregulated activity of Cdk5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

A 24-residue peptide (p5), derived from p35, the Cdk5 neuronal activator, specifically inhibits Cdk5-p25 hyperactivity and tau hyperphosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138

Explaining the inhibition of cyclin-dependent kinase 5 by peptides derived from p25 with molecular dynamics simulations and MM-PBSA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100138